Representatives Rich McCormick of Georgia and Rosa DeLauro of Connecticut introduced the bipartisan Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act on Apr. 9, with Senators Rick Scott and Kirsten Gillibrand leading the bill in the Senate.
The legislation aims to require prescription drug labels to clearly list the original manufacturers of both drugs and their active pharmaceutical ingredients (APIs). This measure is intended to give Americans more information about where their medications come from, addressing concerns over transparency and accountability in the pharmaceutical supply chain.
“I’m proud to be the House co-lead of the CLEAR LABELS Act. This bipartisan and bicameral bill will bring transparency to consumers, pharmacists, and providers about the country of origin of pharmaceuticals and APIs while empowering stakeholders with knowledge of where their medications come from,” said Representative Rich McCormick. “Americans deserve to know where their prescription drugs, or the APIs used to make them, are manufactured. I’m proud to work alongside Representative DeLauro and Senators Scott and Gillibrand to pass this legislation.”
Representative DeLauro said, “American patients deserve to know where their medications and their ingredients come from. Right now, federal law leaves patients, pharmacists, and providers completely in the dark about whether the drugs they rely on were manufactured in a facility with strong safety standards or in a country with weak oversight. The CLEAR LABELS Act changes that. By requiring transparency on the country of origin for finished drug products, active pharmaceutical ingredients, and the key starting materials used to make them, we will begin to address our dangerous overreliance on overseas pharmaceutical supply chains. I’m proud to co-lead this legislation and look forward to working with my colleagues in the House and Senate to make it law.” Senator Scott added that families should have confidence that medicines are safe: “That’s why I’m leading…the CLEAR LABELS Act…to ensure your medicines have clear and upfront country-of-origin labeling…”
Senator Gillibrand said she would continue fighting for access not only safe medications but also clear information: “The CLEAR LABELS Act would shine a light on pharmaceutical manufacturing by making this information readily accessible…while strengthening accountability across the supply chain.”
McCormick has represented Georgia’s 6th district since 2023 after replacing Lucy McBath according to official records. He defeated Bob Christian in 2024’s general election by winning nearly two-thirds of votes according to election data. Born in Las Vegas in 1968, McCormick lives in Suwanee according biographical sources.
Broader implications include increased transparency for consumers regarding medication origins as well as possible changes within international pharmaceutical supply chains if such labeling becomes law.
